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IMPORTANCE Keratinocyte cancers (KCs), including basal cell carcinoma (BCC) and squamous
cell carcinoma (SCC), are themost common cancers among fair-skinned populations
worldwide. Although studies have indicated that the anatomical distribution of BCC and SCC
differ, few have compared them directly in well-defined population samples.
OBJECTIVES To describe and compare the anatomical distribution of BCC and SCC in a
population-based sample in Queensland, Australia.
DESIGN, SETTING, AND PARTICIPANTS This studywas nestedwithin the population-based
QSkin Sun and Health Study in Queensland, Australia. Of 37 103 study participants linked to
national medical insurance records, 3398 diagnosed with KCs from September 1, 2010, to
September 30, 2012, were identified, and information about their KCs was extracted from
pathology reports. Data were analyzed from January 1, 2013, to March 30, 2016.
MAIN OUTCOMES ANDMEASURES The relative tumor densities (RTDs) on defined body sites,
calculated by dividing the proportion of tumors occurring at a specified site by the proportion
of skin area of that site.
RESULTS A total of 5150 KCs with complete data were identified in 2374 study participants
(1339men [56.4%] and 1035 women [43.6%]; mean [SD] age, 59.7 [7.4] years). Of these,
3846 KCs (74.7%) were BCCs. Most BCCs were on the head and/or neck (1547 [40.2%]) and
the trunk (1305 [33.9%]); most SCCs were on the head and/or neck (435 [33.4%]) and upper
limbs (455 [34.9%]). The greatest differences in RTDs between BCC and SCCwere on the
hand (BCC:SCC ratio, 1:14) and the back and/or buttocks (BCC:SCC ratio, 8:1). Relative tumor
densities of KCs were higher on the scalp and ear in men compared with women, and on the
upper arm in women compared with men. The pattern of RTDs did not differ with age for
BCC. Compared with younger adults (40-54 years), the RTDs in older adults (55-69 years)
were 2-fold higher for SCC on the scalp (0.38 [95% CI, 0.00-0.81] vs 1.07 [95% CI, 0.75-1.38])
and the back and/or buttocks (0.05 [95% CI, 0.00-0.12] vs 0.12 [95% CI, 0.07-0.16]).
CONCLUSIONS AND RELEVANCE The high RTDs on sun-exposed body sites for BCC and SCC
are in keeping with sun exposure as the primary etiologic factor for both tumors. However, for
BCC, the low RTD on the hand and high RTDs on less sun-exposed sites suggest a complex
association between sun exposure and occurrence of BCC. Knowledge about the anatomical
distribution of BCC and SCCmay provide insight into their diagnoses and causes.
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B asal cell carcinoma (BCC) and squamous cell carci-noma (SCC), collectively termed keratinocyte cancers(KCs), are the most common cancers among fair-
skinned populations worldwide. Australia has the highest
incidence,1with approximately 434000people (or nearly 2%
of thepopulation) estimated tohavebeendiagnosedwithKCs
in the calendar year 2008.2 The cost ofmanaging KCs in Aus-
tralia was projected to reach A$703 million (US $536 million)
in 2015.3
AlthoughUV radiation is themajor risk factor for BCCand
SCC, their anatomical distributions differ. Squamous cell car-
cinoma occurs primarily on sites habitually exposed to sun-
light, suchas the faceandexposedpartsof theupperand lower
limbs, whereas BCC occurs on these sites and those less fre-
quently exposed to sunlight, such as the trunk.4-15
Most studies report the proportion of tumors on speci-
fied body sites without taking into account the proportion of
surface area of the defined body site, which prevents direct
comparisonof tumorburdenacrossdifferent anatomical sites.
A few studies have reported the relative tumor density
(RTD),5,6,16-19 calculated as the ratio of the proportion of tu-
mors at a specific anatomical site to theproportionof skin sur-
face area at that site, or have reported surface area–adjusted
incidence rates.5-7 These studies5,6,17,18 showed that the high-
est RTDs occurred on the face for both cancers, but analysis
of facial subsites has been limited.
Somestudies suggest that thebodysitedistributionofBCC
andSCCvarieswithageandsex,5,17,18althoughfewstudieshave
compared both tumor types from 1 population sample. Given
the relatively smallnumberof studies reported todate, theaim
ofour studywas tocompare theanatomicaldistributionofBCC
and SCC arising in participants from a large, population-
based cohort in Queensland, Australia, and to investigate
differences according to age and sex.
Methods
This study is nested within the QSkin Sun and Health Study,
which consists of 43 794 residents of Queensland, Australia.
Participants aged40 to69yearswere randomly selected from
the Australian electoral roll (enrollment to vote is compul-
sory) and recruited in 2010. They completed a survey that in-
cludedquestionsaboutancestry, lifestyle, skinphenotype,past
treatment of skin lesions, and sunexposurehistory.Details of
the survey have been published previously.20 This studywas
approved by the human ethics committees of theQIMRBerg-
hofer Medical Research Institute and Queensland University
of Technology, Brisbane, Queensland. All participants pro-
videdwritten informedconsent for linkageof recordswith the
Medicare Australia database.
Through record linkage toMedicare Australia, Australia’s
national health insurance scheme, we identified participants
in theQSkin cohortwhohadbeen treated for skin cancer from
September 1, 2010, to September 30, 2012. Medicare Austra-
lia subsidizes health care for all Australians and records infor-
mation about medical services to Australian residents, ex-
cept for some services delivered in public hospitals. The data
held by Medicare Australia records medical billing events for
KCsandthe typeofprocedureundertaken,butnodetails about
histologic type or specific anatomical site are recorded. We
therefore obtained the corresponding pathology reports for
each treatment event by linking our QSkin data set to pathol-
ogyserviceproviders for thoseparticipants identified fromthe
Medicare Australia data as having had KC treatments.
Thediagnosis, treatment procedures, and anatomical site
of each tumor were manually abstracted from the pathology
reports. We included only primary BCCs and SCCs; recurrent
lesions, defined as the regrowth of a previously treated ma-
lignant neoplasm,were excluded. Thus,we cross-checked all
biopsies, excisions, andreexcisionsofapparentlymultipleBCC
orSCC lesionsdiagnosedwithina6-monthperiodon the same
anatomical site in the same person inMedicare Australia rec-
ords and pathology reports and omitted verified recurrent le-
sions from our analysis.
Analysis
Datawere analyzed from January 31, 2013, toMarch 30, 2016.
We were able to match 65% of individual Medicare Australia
claims for KC treatment (72.1% of people) with pathology re-
ports. Themedian follow-up duration of the participantswas
12.6 (range, 4.0-19.8)months. Almost all lesions forwhichwe
had pathology reports (99.5%) had complete information on
body site and histologic findings and were included in the
analysis. Toallow fordifferences in the skin surface area atdif-
ferent body sites, the RTD for each body site was calculated
by dividing the proportion of tumors at a defined anatomical
site by the mean proportion of the skin surface area of that
site.16 AnRTDof 1 corresponds to thedensity of tumors on the
whole body.
Theproportionof thesurfaceareaof skinattributedtoeach
bodysitewasbasedontheestimatedproportionof surfacearea
describedbyLundandBrowder.21Weclassifiedbodysites into
4 broad areas—head and/or neck, trunk (including shoul-
ders), upper limbs, and lower limbs—that constituted 9.0%,
32.0%, 19.0%, and 40.0% of the skin surface, respectively.
These 4 body sites were further subdivided into subsites as
Key Points
Question How great are the differences in anatomical
distributions of basal cell carcinoma (BCC) and squamous cell
carcinoma (SCC)?
Findings In this population-based study, the anatomical
distribution of 3398 keratinocyte cancers arising during 2 years of
follow-up of 37 103 Australians consisted of BCCs primarily on the
head and neck and trunk and SCCs predominantly on the upper
limbs and head and neck. Sites with the greatest discrepancy in
relative tumor densities between BCC and SCCwere the hand and
back and buttocks.
Meaning Basal cell carcinoma and SCC have high relative tumor
densities on the head, consistent with sun exposure as the primary
etiologic factor; however, for BCC, the low relative tumor densities
on the hand and high relative tumor densities on less sun-exposed
sites suggest a complex association with sun exposure.
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shown in Table 1. The classification of facial subsites accord-
ing to their sun exposure was adapted and modified from
previous studies5,6 as follows: most exposed included the
ears, nose, cheeks, and lips; less exposed, the forehead, eye-
brows, chin, jaw, temple, and preauricular area; and least ex-
posed,under theeyebrow,upperand lowereyelids,medial and
lateral canthus, and nasolabial fold.
Wecalculated theRTDsand95%CIs forBCCandSCCover-
all andwithin thestrataof sexandagegroups (40-54and55-69
years).We calculated the ratio ofRTDs for BCC to SCC for each
anatomical site and95%CIs of these ratios, overall andwithin
strataof ageandsex.22Statistical analysiswasconductedusing
SAS (version 9.4; SAS Institute, Inc) and Excel (Microsoft)
software.
Results
Of the 43 794 QSkin participants, 39033 consented to link-
age with Medicare and 37 103 were linked to the Medicare
Australia database (Figure 1). Of these, we identified 3398
participants who were treated for KCs during the study
period. Histopathology reports for at least 1 KC lesion were
retrieved and matched for 2387 of these participants (70.2%)
(1346 men [56.4%] and 1041 women [43.6%]; mean [SD] age,
59.7 [7.4] years). Participants with available histopathologic
data were similar with respect to age and sex to those with-
out available data.
Most participants reportedhavingwhiteEuropean ances-
try (2327 [97.5%]) and 1473 (68.3%) had lived longest as a
child or youth in the north and central regions (10°S-30° S
parallels) of Australia. For skin characteristics, 1820 partici-
pants (76.3%) had fair skin, 2265 (94.9%) reported that their
skin burned after exposure to 30minutes ofmidday sun, and
2079 (87.1%) reported that they tanned after long-term sun
exposure.
From the pathology reports, we identified 5189 primary
KC lesions in2387participants.Weexcluded39BCCsandSCCs
from13participantswithmissing site information.Of the5150
KCs from2374participants included in the final analysis, 3846
(74.7%)wereBCCs.Of these, 3233 lesions (62.8%)were treated
inmen and 2891 (57.3%)were treated in people aged 60 to 69
years. Among the participants with a histologically con-
firmedBCCorSCC,806(42.6%)hadmultipleBCCs (range,2-40
lesions), and 223 (28.1%) had multiple SCCs (range 2-8 le-
sions). Three hundred eight participants (12.9%of thosewith
KC) had both BCC and SCC. Of thosewith BCC, 16.3% also had
SCC, and of those with SCC, 38.7% also had BCC.
Table 1. Proportions, RTDs, and BCC:SCC Ratio by Body Site
Body Site
Body Surface
Area, %
BCC Lesions
(n = 3846)
SCC Lesions
(n = 1304)
BCC to SCC Ratio
(95% CI)No. (%) [95% CI] RTD (95% CI)a No. (%) [95% CI] RTD (95% CI)a
Head and/or neck 9.0 1547 (40.2) [39-42] 4.47 (4.30-4.64) 435 (33.4) [31-36] 3.71 (3.42-3.99) 1.2 (1.1-1.3)
Scalp 3.7 89 (2.2) [2-3] 0.63 (0.50-0.75) 46 (3.5) [3-5] 0.95 (0.68-1.22) 0.7 (0.5-0.9)
Ears 0.5 138 (3.6) [3-4] 7.18 (6.00-8.35) 54 (4.1) [3-5] 8.28 (6.12-10.45) 0.9 (0.6-1.2)
Face 2.4 1086 (28.2) [27-30] 11.77 (11.17-12.36) 295 (22.6) [20-25] 9.43 (8.48-10.37) 1.3 (1.1-1.4)
Most exposedb 1.3 712 (18.5) [17-20] 14.24 (13.30-15.18) 213 (16.6) [14-18] 12.56 (11.02-14.11) 1.1 (1.0-1.3)
Less exposedc 1.3 384 (10.0) [9-11] 7.68 (6.95-8.41) 107 (8.2) [7-10] 6.31 (5.17-7.46) 1.2 (1.0-1.5)
Least exposedd 0.3 129 (3.4) [3-4] 11.18 (9.28-13.08) 29 (2.2) [1-3] 7.41 (4.75-10.08) 1.5 (1.0-2.2)
Neck 2.4 234 (6.1) [5-7] 2.54 (2.22-2.85) 40 (3.1) [2-4] 1.28 (0.89-1.67) 2.0 (1.4-2.8)
Trunk 32.0 1305 (33.9) [32-35] 1.06 (1.01-1.11) 109 (8.4) [7-10] 0.26 (0.21-0.31) 4.1 (3.4-4.9)
Chest and/or
abdomen
13.0 647 (16.8) [15-18] 1.29 (1.20-1.38) 83 (6.4) [5-8] 0.49 (0.39-0.59) 2.6 (2.1-3.3)
Back and/or
buttocks
19.0 658 (17.1) [16-18] 0.90 (0.84-0.96) 26 (2.0) [1-3] 0.10 (0.07-0.14) 8.6 (5.8-12.6)
Upper limbs 19.0 528 (13.7) [13-15] 0.72 (0.67-0.78) 455 (34.9) [32-37] 1.84 (1.70-1.97) 0.4 (0.4-0.4)
Upper arm 8.0 234 (6.1) [5-7] 0.76 (0.67-0.85) 56 (4.3) [3-5] 0.54 (0.40-0.67) 1.4 (1.1-1.9)
Forearm 6.0 257 (6.7) [6-8] 1.11 (0.98-1.25) 223 (17.1) [15-19] 2.85 (2.51-3.19) 0.4 (0.3-0.5)
Hande 5.0 37 (1.0) [1-1] 0.19 (0.13-0.25) 176 (13.5) [12-15] 2.70 (2.33-3.07) 0.1 (0.1-0.1)
Lower limbs 40.0 466 (12.1) [11-13] 0.30 (0.28-0.33) 305 (23.4) [21-26] 0.58 (0.53-0.64) 0.5 (0.5-0.6)
Thigh 19.0 67 (1.7) [1-2] 0.09 (0.07-0.11) 30 (2.3) [1-3] 0.12 (0.08-0.16) 0.8 (0.5-1.2)
Lower leg 14.0 377 (9.8) [9-11] 0.70 (0.63-0.77) 258 (19.8) [18-22] 1.41 (1.26-1.57) 0.5 (0.4-0.6)
Footf 7.0 22 (0.6) [0-1] 0.08 (0.05-0.12) 17 (1.3) [1-2] 0.19 (0.10-0.27) 0.4 (0.2-0.8)
All 100 NA NA NA NA NA
Abbreviations: BCC, basal cell carcinoma; NA, not applicable; RTD, relative
tumor density; SCC, squamous cell carcionoma.
a Calculated as the ratio of the proportion of tumors at a specific anatomical site
to the proportion of skin surface area at that site.
b Includes ears, nose, cheeks, and lips.
c Includes forehead, eyebrows, chin, jaw, temple, and preauricular area.
d Includes under eyebrow, upper and lower eyelids, medial and lateral canthus,
and nasolabial fold.
e Includes back of hand, palmar skin, and fingernail.
f Includes dorsum of foot, toes, plantar skin, and toenail.
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Anatomical Distribution of BCC and SCC
The most commonly diagnosed sites of the 3846 identified
BCCswereon theheadand/orneck (40.2%)and trunk (33.9%).
The 1304 SCCs occurred with similar frequency on the upper
limbs (34.9%) and head and/or neck (33.4%) (Table 1 and
Figure 2). Although the differences in the proportion of le-
sions on the most commonly affected sites were small, we
foundmarked differences in the RTDs oncewe accounted for
the surface area of these sites (Table 1, Figure 2, andFigure 3).
ForBCCs,highestRTDswereobservedontheheadand/orneck
(RTD,4.47; 95%CI, 4.30-4.64),whichwas4 timeshigher than
on the trunk, the second most commonly affected site (RTD,
1.06; 95% CI, 1.01-1.11). Similarly, SCCs occurred at highest
densityontheheadand/orneckregion (RTD,3.71;95%CI,3.42-
3.99),whichwas twiceashighas thaton theupper limbs (RTD,
1.84; 95% CI, 1.70-1.97).
Subsites with the highest RTDs for BCC were the most
(14.24; 95% CI, 13.30-15.18) and least (11.18; 95% CI, 9.28-
13.08) sun-exposed face. The lowest RTDs for BCC
were observed on the foot (0.08; 95% CI, 0.05-0.12), thigh
(0.09; 95% CI, 0.07-0.11), and hand (0.19; 95% CI,
0.13-0.25). Sites with the highest RTDs for SCC were the
most sun-exposed face (12.56; 95% CI, 11.02-14.11) and ears
(8.28; 95% CI, 6.12-10.45). The lowest RTDs of SCC were
observed on the back and/or buttocks (0.10; 95% CI, 0.07-
0.14), thigh (0.12; 95% CI, 0.08-0.16), and foot (0.19; 95%
CI, 0.10-0.27).
The greatest disparity in RTD was seen on the hand, for
which the RTD for SCC was 14 times higher than that for BCC
(2.70 [95% CI, 2.33-3.07] vs 0.19 [95% CI, 0.13-0.25]). At the
other extreme, BCCs occurred on the back and/or buttocks at
amore than8-fold higherRTD (0.90; 95%CI, 0.84-0.96) than
SCCs (0.10; 95%CI, 0.07-0.14) (Table 1). Overall, RTDs for SCC
on theupper and lower limbswere almost twice those of BCC,
whereas BCCs were twice as dense as SCCs on the neck and
chest and/or abdomen. For participants with multiple le-
sions, theRTDs on the body sites followed a similar pattern of
distribution to the overall distribution of lesions (eTable 1 in
the Supplement).
Figure 1. Outline of Data Collection Process for the Study Participants
43 794 Participants in QSkin cohort
39 033 (89.1%) Consent for Medicare
Australia linkage
37 103 (95.1%) Linkage with Medicare
Australia data
3398 (9.2%) Treated for keratinocyte
cancersa, b
3846 (74.7%) Lesions are BCC 1304 (25.3%) Lesions are SCC
2374 Participants (5150 lesions)
with complete data
13 Participants (39 lesions) with
incomplete data (not included)
2387 Participants (5189 lesions) with
histology reports diagnosing
keratinocyte cancersc 
The number of basal cell carcinoma (BCC) (n = 3846) and squamous cell
carcinoma (SCC) (n = 1304) lesions included in the analysis was derived from
participants recruited for the QSkin Sun and Health Study, who gave consent for
linkage with Medicare Australia, were treated for keratinocyte cancers, and had
histologic verification of BCC and SCC.
a Includes excision and destructive therapies.
b Includes treatment for BCC, SCC, intraepidermal carcinoma, and
keratoacanthoma.
c Includes BCC and SCC only.
Figure 2. Relative Tumor Densities of Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) by Body Sites
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Sex Differences in the Anatomical Distribution
of BCC and SCC
For BCC, we found little difference betweenmen andwomen
in the RTDs overall, except that the relative density of BCCs
on the ears and scalpwere 3.7-fold (2.68 [95%CI, 1.51-3.84] vs
10.03 [95% CI, 8.27-11.80]) and 1.6-fold (0.45 [95% CI, 0.28-
0.63] vs0.74 [95%CI, 0.56-0.91]), respectively, higher inmen
than in women. In contrast, BCCs occurred 80% more fre-
quently (in relative terms) on the upper arms of women than
men (RTDs, 1.05 [95% CI, 0.87-1.22] vs 0.58 [95% CI, 0.47-
0.69]).TheoccurrenceofBCConthefacewasmarginallyhigher
inwomen thanmen (13.61 [95%CI, 12.14-14.49] vs 10.60 [95%
CI, 9.68-11.33]); this was most marked on the least exposed
areas of the face (13.83 [95% CI, 10.46-17.20]vs 9.50 [95% CI,
7.25-11.74]; 1.5-fold higher) (eTable 2 in the Supplement).
In contrast, the site distribution of SCCdifferedmarkedly
betweenmen andwomen, with RTDs inmen 10 times higher
on the scalp (1.35 [95% CI, 0.96-1.74] vs 0.13 [95% CI, 0.00-
0.30]) and 5 times higher on the ears (11.12 [95% CI, 8.10-
14.15]vs2.36[95%CI,0.30-4.42]) comparedwithwomen.With
the exception of the forearm, the RTDs of SCC on the trunk
(0.23 [95%CI, 0.18-0.28] vs0.33 [95%CI, 0.23-0.42]) andup-
per (1.74 [95% CI, 1.57-1.90] vs 2.04 [95% CI, 1.80-2.28]) and
lower (0.52 [95% CI, 0.45-0.59] vs 0.72 [95% CI, 0.61-0.83])
limbs was higher in women than in men.
Age Differences in the Anatomical Distribution
of BCC and SCC
ThedistributionsofBCCweresimilaramongyoungerandolder
participants (Table 2) at all anatomical sites. For SCC, higher
RTDswere seen on the scalp (0.38 [95%CI, 0.00-0.81] vs 1.07
[95%CI,0.75-1.38]), ears (5.63 [95%CI, 1.19-10.08]vs8.80[95%
CI, 6.37-11.23]), andback and/or buttocks (0.05 [95%CI, 0.00-
0.12] vs 0.12 [95% CI, 0.07-0.16]) in the older compared with
theyoungerparticipants.Althoughnumberswere small, some
evidencesuggested that theRTDofSCCsonthe facewashigher
amongyounger thanolder people, especially on the least sun-
exposed facial sites.
Amongyounger participants, theRTDofBCCon the scalp
was higher than the RTD of SCC on the scalp (0.84 [95% CI,
0.56-1.13] vs 0.38 [95% CI, 0.00-0.81]), whereas the opposite
was observed among older participants (0.54 [95% CI, 0.40-
0.68] vs 1.07 [95% CI, 0.75-1.38]). On the back and buttocks,
theRTDofBCC comparedwith SCCwas 18-fold higher among
youngerparticipants (0.91 [95%CI,0.79-1.03] vs0.05 [95%CI,
0.00-0.12]), but just more than 7-fold higher among older
participants (0.90 [95% CI, 0.82-0.97] vs 0.12 [95% CI,
0.07-0.16]).
Discussion
In this study,we analyzed the anatomical site distributions of
BCCandSCCand compared themwithin strata of age and sex.
This study is, to our knowledge, oneof the largest population-
based studies to compare the site distribution of BCCandSCC
within the same sample of participants.
Comparedwith thewhole body, the head and/or neck re-
gion (face, ears, and neck) had a higher RTD of BCC than the
mean. Although the RTD of BCC was highest on sites of fre-
quent sun exposure, a large number of lesions also occurred
on body sites less frequently exposed to sunlight, particu-
larly the trunk. For SCC,RTDshigher than themeanwere seen
on the frequently sun-exposedpartsof thebody,with thehead
and/or neck region (face, ears, and neck), upper limbs (fore-
arm and hands), and lower legs all exhibiting high RTDs. The
highest RTDs were present on the most sun-exposed facial
sites, followed by the ears.
The pattern of distribution5,6,18 and the absolute tumor
densities17 of BCCandSCCwere consistentwith otherAustra-
lianstudies.However, studies fromother countrieshave found
a much higher proportion of both cancer types on the head
and/or neck region, with as many as 80% of BCCs and SCCs
occurring on this site.7-15,23,24 A number of possible reasons
may explain this frequency. First, these studies differed in
age range of the participants and methodologic approach.
Figure 3. Relative Tumor Densities (95%CIs) of Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC)
at Different Body Sites
Basal cell carcinomaA Squamous cell carcinomaB Head and/or neck
Upper limbs
Trunk
Lower limbs
3.71 (95% CI, 3.42-3.99)
0.26 (95% CI, 0.21-0.31)
1.84 (95% CI, 1.70-1.97)
0.58 (95% CI, 0.53-0.64)
4.47 (95% CI, 4.30-4.64)
1.06 (95% CI, 1.01-1.11)
0.72 (95% CI, 0.67-0.78)
0.30 (95% CI, 0.28-0.33)
Relative tumor density is calculated
as the ratio of the proportion of
tumors at a specific anatomical site to
the proportion of skin surface area at
that site. Bodymaps show the
relative tumor densities of BCC and
SCC according to the following body
site classifications: head and/or neck
(total body surface area, 9.0%), trunk
(total body surface area, 32.0%),
upper limbs (total body surface area,
19.0%), and lower limbs (total body
surface area, 40.0%).
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Second, variability inmedical care, such as differences in op-
portunistic screening practice, may have led to fewer lesions
being diagnosed on less habitually sun-exposed sites than in
Australia. This variability is particularly likely to influence the
body site distribution of BCC.25 Finally, the relatively higher
proportion of lesions on sites other than thehead and/or neck
in Australia is likely owing to lifestyle and sun exposure
practices. For example, the climate in Australia is conducive
to outdoor recreational pursuits that are commonly enjoyed
with minimal clothing, which would contribute to higher
exposure on the trunk and limbs compared with other
populations.
The anatomical distribution of SCC corresponds closely
to the pattern of intensity of sun exposure, with the highest
density of lesions occurring on body sites frequently
exposed to sunlight. Basal cell carcinoma was less clearly
aligned with sun exposure patterns, with a relatively high
RTD on less frequently exposed body sites. The infrequent
exposure of these sites results in less melanin protection,
increasing the risk for sunburn. Basal cell carcinoma on less
exposed body sites may thus arise as a result of infrequent
or intermittent high doses of UV radiation.26 Alternatively,
the potential cells of origin of BCC on the trunk and but-
tocks may require a lower total dose of sun exposure to
become neoplastic. The relatively high RDT of BCC in the
periorbital region, which receives the least amount of
sunlight among the facial subsites, also supports the theory
that lower doses of UV radiation give rise to BCCs compared
with SCCs.
The RTD of SCC on the handwas 14 times higher than the
RTD of BCC (2.70 [95% CI, 2.33-3.07] vs 0.19 [95% CI, 0.13-
0.25]). The relative paucity of BCC on the hands, which are
chronically exposed to intense sunlight, has been reported in
clinical and epidemiologic studies previously.16,27 We calcu-
lated theBCC:SCC ratio in previous studies as 1:918 and 1:20.16
The difference in RTDs between BCC and SCC on the hands
cannot be explained simply by sun-exposure patterns. The
significantly greater thickness of the epidermis on the dor-
sum of the hand compared with the forearm28 may explain
the relative lack of BCC on the hands but fails to explain the
relative abundance of SCC. Basal cell carcinoma is postu-
lated to arise from basal cells that are situated deeper in the
epidermis of the skin, in contrast to the more superficially
placed squamous cells, thought to be the origin of SCC.
Thus, one plausible explanation for the marked differences
in the occurrence of BCC and SCC on the dorsum of the
hand is that the depth of epidermis protects the deeply situ-
ated basal cells from the UV rays compared with the expo-
sure received by the more superficial squamous cells. Stud-
ies have also suggested that BCC may arise from follicular
stem cells,29 so an alternate explanation for the lower RTD
of BCC could be the relative lack of hair on the back of the
hands compared with the forearm.
A limited number of studies have shown that the associa-
tion between the anatomical distributions of KC varies
according to sex. We found that the RTDs of BCC and SCC on
the scalp and ears were higher in men than in women, a pat-
tern that has been reported previously.6,7,18 This difference
is likely owing to sex differences in hair cover. Higher densi-
ties of KCs occurring on the upper arm of women compared
with men may be attributed to clothing choice, with more
women than men choosing to wear short-sleeved or sleeve-
less shirts.
Our findings did not show significant differences be-
tween the younger and theolder groups for BCC.HigherRTDs
for SCCs seen on less exposed sites, such as the back and/or
buttocks region, in older compared with younger partici-
pants could be attributed to higher cumulative sun exposure
with increasingage.Differential treatmentaccording toage (eg,
older people having more regular full-body screening) may
partly explain the age differences in SCC RTDs but is unlikely
tobeentirely responsiblebecause the samedifferences arenot
observed for BCC.
This study has a number of strengths and weaknesses.
We recruited a large community-based sample from the
compulsory voting register. Moreover, because we identi-
fied patients with KCs through linkage with the national
insurance scheme and confirmed the diagnoses with
pathology reports, the information regarding diagnosis and
anatomical distribution is likely to be accurate. Although we
did not capture services delivered in public hospitals, the
2002 National Skin Cancer Survey reported that fewer than
2% of the survey participants underwent skin cancer treat-
ment in a hospital setting, indicating near-complete capture
of skin cancer events.30 A potential weakness in this analy-
sis is the lack of histologic confirmation of all KCs identified
in the Medicare records. We obtained pathology records
from the 2 largest and 2 smaller pathology service providers
for the state of Queensland, but we were unable to obtain
pathology reports from all laboratories in the state. How-
ever, we interrogated the Medicare data by item numbers
that broadly identify the site of the lesion, which showed
that the overall patterns of site distribution did not differ
between participants with and without pathology reports.
Therefore, the RTD estimates are likely to be representative
of the fair-skinned population of Queensland, and by infer-
ence to other populations residing in low latitudes,
although they may not be applicable to other population
groups.
Conclusions
The results from this large cohort study emphasized dif-
ferences in the anatomical distributions of BCC and SCC.
High densities of BCCs and SCCs observed on sun-exposed
body sites confirm sun exposure as the primary etiologic
factor for both tumors; the differences in RTDs of SCCs
by age and sex underscore the association with cumulative
sun exposure. In contrast, the observations that BCCs
occur relatively infrequently on the hand but relatively fre-
quently on body sites that are only intermittently exposed
to UV radiation point to more complex associations
with sun exposure. Understanding the etiology and patho-
genesis of BCC may lead to new avenues for prevention and
treatment.
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